Unlike LCN2 roles in metabolic disorders, mechanistic studies conducted on LCN2-KO mice have demonstrated possible cause–effect relationships between LCN2 and the development of atherosclerotic disease (Figure 2). Here, LCN2 is linked to Other metabolic disease.